Page 188 - NobleCon20-Book-Project
P. 188

Health Care
      Date                  November 18, 2024      Health Care
      52wk High                         $0.23
      52wk Low                          $0.12      Zomedica Corp.                            ZOM       $0.13
                                                   100 Phoenix Drive
                                                   Ann Arbor, MI 48108

                               (USD - in millions)  www.zomedica.com
      Market Cap                       135.2
      Enterprise                        60.4
      Basic Shares Out.               979.95       COMPANY OVERVIEW
      Float                           961.66
      Institutional Holdings           8.32%      Detailed Analysis:Channelchek.com
      Short Interest                   52.60      Zomedica is a leading equine and companion animal healthcare
      Avg. 90-Day Volume                4.50      company dedicated to improving animal health by providing
                                                  veterinarians innovative therapeutic and diagnostic solutions. Our gold
                                                  standard PulseVet® shock wave system, which accelerates healing in
                                                  musculoskeletal conditions, has transformed veterinary therapeutics.
      EPS Data                                    Our suite of products also includes the Assisi® Loop line of therapeutic
                                                  devices and the TRUFORMA® diagnostic platform, the TRUVIEW™
                     2022     2023       2024     digital cytology system, and the VetGuardian® no-touch monitoring
      CQ1             N/A       N/A       N/A     system, all designed to empower veterinarians to provide top-tier care.
      CQ2             N/A       N/A       N/A     In the aggregate, their total addressable market in the U.S. exceeds $2
                                                  billion.
      CQ3           (0.01)    (0.00)    (0.01)
      CQ4             N/A       N/A     (0.01)
      CY            (0.02)    (0.04)    (0.05)                                           Source: Channelchek/QuoteMedia




      Long-Term EPS Estimate              N/A
      Price/Book (mrq)                   0.21
      ROE (ttm)                        -26.82
      Debt-to-Total Cap. (mrq)           1.01
      Fiscal Year End                 31-Dec
                                                   100 Phoenix DAnn Arbor          MI              48108



      Key Executives
      CEO:      Heaton, Larry
      CFO:      N/A
      COO:      Blair, Anthony
      IR:       N/A
                                                           Noble Capital Markets, Inc.
      Source: Capital IQ, Noble Financial estimates, company filings
      Noble Senior Analyst                                 561-994-1191   noblecapitalmarkets.com
      Robert LeBoyer                                       MEMBERS: FINRA, SIPC, MSRB
                                                           Following the conference, complete video library of presentations will be
      rleboyer@noblelsp.com                                available at: channelchek.com | nobleconference.com
      (212) 896-4625


      Refer to the back of the book for disclosures
   183   184   185   186   187   188   189   190